Neurodegenerative Disease Treatment Market, Global Outlook and Forecast 2023-2028

Report ID: 1134280 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Neurodegenerative Disease Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Neurodegenerative Disease Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Neurodegenerative Disease Treatment Overall Market Size
    2.1 Global Neurodegenerative Disease Treatment Market Size: 2021 VS 2028
    2.2 Global Neurodegenerative Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Neurodegenerative Disease Treatment Players in Global Market
    3.2 Top Global Neurodegenerative Disease Treatment Companies Ranked by Revenue
    3.3 Global Neurodegenerative Disease Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Neurodegenerative Disease Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Neurodegenerative Disease Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Neurodegenerative Disease Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Neurodegenerative Disease Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Neurodegenerative Disease Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Neurodegenerative Disease Treatment Market Size Markets, 2021 & 2028
        4.1.2 Neurotransmitter Agents
        4.1.3 Neuroprotective Agents
        4.1.4 Biologics
        4.1.5 Others
    4.2 By Type - Global Neurodegenerative Disease Treatment Revenue & Forecasts
        4.2.1 By Type - Global Neurodegenerative Disease Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Neurodegenerative Disease Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Neurodegenerative Disease Treatment Market Size, 2021 & 2028
        5.1.2 Multiple Sclerosis [MS]
        5.1.3 Alzheimer’s Disease
        5.1.4 Parkinson's Disease
        5.1.5 Acute Migraine
        5.1.6 Autism
        5.1.7 Narcolepsy
        5.1.8 Amyotrophic Lateral Sclerosis [ALS]
        5.1.9 Attention Deficit Hyperactivity Disorder [ADHD]
        5.1.10 Spinal Muscular Atrophy
        5.1.11 Huntington's Disease
    5.2 By Application - Global Neurodegenerative Disease Treatment Revenue & Forecasts
        5.2.1 By Application - Global Neurodegenerative Disease Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Neurodegenerative Disease Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Neurodegenerative Disease Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Neurodegenerative Disease Treatment Revenue & Forecasts
        6.2.1 By Region - Global Neurodegenerative Disease Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Neurodegenerative Disease Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Neurodegenerative Disease Treatment Revenue, 2017-2028
        6.3.2 US Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.3.3 Canada Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.3.4 Mexico Neurodegenerative Disease Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Neurodegenerative Disease Treatment Revenue, 2017-2028
        6.4.2 Germany Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.4.3 France Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.4.4 U.K. Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.4.5 Italy Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.4.6 Russia Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.4.8 Benelux Neurodegenerative Disease Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Neurodegenerative Disease Treatment Revenue, 2017-2028
        6.5.2 China Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.5.3 Japan Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.5.4 South Korea Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.5.6 India Neurodegenerative Disease Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Neurodegenerative Disease Treatment Revenue, 2017-2028
        6.6.2 Brazil Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.6.3 Argentina Neurodegenerative Disease Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Neurodegenerative Disease Treatment Revenue, 2017-2028
        6.7.2 Turkey Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.7.3 Israel Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Neurodegenerative Disease Treatment Market Size, 2017-2028
        6.7.5 UAE Neurodegenerative Disease Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Allergan plc
        7.1.1 Allergan plc Corporate Summary
        7.1.2 Allergan plc Business Overview
        7.1.3 Allergan plc Neurodegenerative Disease Treatment Major Product Offerings
        7.1.4 Allergan plc Neurodegenerative Disease Treatment Revenue in Global Market (2017-2022)
        7.1.5 Allergan plc Key News
    7.2 Bayer AG
        7.2.1 Bayer AG Corporate Summary
        7.2.2 Bayer AG Business Overview
        7.2.3 Bayer AG Neurodegenerative Disease Treatment Major Product Offerings
        7.2.4 Bayer AG Neurodegenerative Disease Treatment Revenue in Global Market (2017-2022)
        7.2.5 Bayer AG Key News
    7.3 F. Hoffmann La-Roche Ltd.
        7.3.1 F. Hoffmann La-Roche Ltd. Corporate Summary
        7.3.2 F. Hoffmann La-Roche Ltd. Business Overview
        7.3.3 F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Major Product Offerings
        7.3.4 F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Revenue in Global Market (2017-2022)
        7.3.5 F. Hoffmann La-Roche Ltd. Key News
    7.4 GlaxoSmithKline plc
        7.4.1 GlaxoSmithKline plc Corporate Summary
        7.4.2 GlaxoSmithKline plc Business Overview
        7.4.3 GlaxoSmithKline plc Neurodegenerative Disease Treatment Major Product Offerings
        7.4.4 GlaxoSmithKline plc Neurodegenerative Disease Treatment Revenue in Global Market (2017-2022)
        7.4.5 GlaxoSmithKline plc Key News
    7.5 Johnson & Johnson
        7.5.1 Johnson & Johnson Corporate Summary
        7.5.2 Johnson & Johnson Business Overview
        7.5.3 Johnson & Johnson Neurodegenerative Disease Treatment Major Product Offerings
        7.5.4 Johnson & Johnson Neurodegenerative Disease Treatment Revenue in Global Market (2017-2022)
        7.5.5 Johnson & Johnson Key News
    7.6 Merck KGaA
        7.6.1 Merck KGaA Corporate Summary
        7.6.2 Merck KGaA Business Overview
        7.6.3 Merck KGaA Neurodegenerative Disease Treatment Major Product Offerings
        7.6.4 Merck KGaA Neurodegenerative Disease Treatment Revenue in Global Market (2017-2022)
        7.6.5 Merck KGaA Key News
    7.7 Novartis AG
        7.7.1 Novartis AG Corporate Summary
        7.7.2 Novartis AG Business Overview
        7.7.3 Novartis AG Neurodegenerative Disease Treatment Major Product Offerings
        7.7.4 Novartis AG Neurodegenerative Disease Treatment Revenue in Global Market (2017-2022)
        7.7.5 Novartis AG Key News
    7.8 Pfizer, Inc.
        7.8.1 Pfizer, Inc. Corporate Summary
        7.8.2 Pfizer, Inc. Business Overview
        7.8.3 Pfizer, Inc. Neurodegenerative Disease Treatment Major Product Offerings
        7.8.4 Pfizer, Inc. Neurodegenerative Disease Treatment Revenue in Global Market (2017-2022)
        7.8.5 Pfizer, Inc. Key News
    7.9 Sanofi
        7.9.1 Sanofi Corporate Summary
        7.9.2 Sanofi Business Overview
        7.9.3 Sanofi Neurodegenerative Disease Treatment Major Product Offerings
        7.9.4 Sanofi Neurodegenerative Disease Treatment Revenue in Global Market (2017-2022)
        7.9.5 Sanofi Key News
    7.10 Teva Pharmaceutical Industries Ltd.
        7.10.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
        7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
        7.10.3 Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Major Product Offerings
        7.10.4 Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Revenue in Global Market (2017-2022)
        7.10.5 Teva Pharmaceutical Industries Ltd. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Neurodegenerative Disease Treatment Market Opportunities & Trends in Global Market
    Table 2. Neurodegenerative Disease Treatment Market Drivers in Global Market
    Table 3. Neurodegenerative Disease Treatment Market Restraints in Global Market
    Table 4. Key Players of Neurodegenerative Disease Treatment in Global Market
    Table 5. Top Neurodegenerative Disease Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Neurodegenerative Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Neurodegenerative Disease Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Neurodegenerative Disease Treatment Product Type
    Table 9. List of Global Tier 1 Neurodegenerative Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Neurodegenerative Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Neurodegenerative Disease Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Neurodegenerative Disease Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Neurodegenerative Disease Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Neurodegenerative Disease Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Neurodegenerative Disease Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Neurodegenerative Disease Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Allergan plc Corporate Summary
    Table 31. Allergan plc Neurodegenerative Disease Treatment Product Offerings
    Table 32. Allergan plc Neurodegenerative Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Bayer AG Corporate Summary
    Table 34. Bayer AG Neurodegenerative Disease Treatment Product Offerings
    Table 35. Bayer AG Neurodegenerative Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. F. Hoffmann La-Roche Ltd. Corporate Summary
    Table 37. F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Product Offerings
    Table 38. F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. GlaxoSmithKline plc Corporate Summary
    Table 40. GlaxoSmithKline plc Neurodegenerative Disease Treatment Product Offerings
    Table 41. GlaxoSmithKline plc Neurodegenerative Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Johnson & Johnson Corporate Summary
    Table 43. Johnson & Johnson Neurodegenerative Disease Treatment Product Offerings
    Table 44. Johnson & Johnson Neurodegenerative Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Merck KGaA Corporate Summary
    Table 46. Merck KGaA Neurodegenerative Disease Treatment Product Offerings
    Table 47. Merck KGaA Neurodegenerative Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Novartis AG Corporate Summary
    Table 49. Novartis AG Neurodegenerative Disease Treatment Product Offerings
    Table 50. Novartis AG Neurodegenerative Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Pfizer, Inc. Corporate Summary
    Table 52. Pfizer, Inc. Neurodegenerative Disease Treatment Product Offerings
    Table 53. Pfizer, Inc. Neurodegenerative Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Sanofi Corporate Summary
    Table 55. Sanofi Neurodegenerative Disease Treatment Product Offerings
    Table 56. Sanofi Neurodegenerative Disease Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. Teva Pharmaceutical Industries Ltd. Corporate Summary
    Table 58. Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Product Offerings
    Table 59. Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Neurodegenerative Disease Treatment Segment by Type in 2021
    Figure 2. Neurodegenerative Disease Treatment Segment by Application in 2021
    Figure 3. Global Neurodegenerative Disease Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Neurodegenerative Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Neurodegenerative Disease Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Neurodegenerative Disease Treatment Revenue in 2021
    Figure 8. By Type - Global Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
    Figure 12. US Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
    Figure 24. China Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Neurodegenerative Disease Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Neurodegenerative Disease Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Allergan plc Neurodegenerative Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Bayer AG Neurodegenerative Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. GlaxoSmithKline plc Neurodegenerative Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Johnson & Johnson Neurodegenerative Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Merck KGaA Neurodegenerative Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Novartis AG Neurodegenerative Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Pfizer, Inc. Neurodegenerative Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Sanofi Neurodegenerative Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Neurodegenerative Disease Treatment Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neurodegenerative Disease Treatment Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neurodegenerative Disease Treatment Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports